These results revealed that miR-183-5p in HCC cell-derived EVs promoted angiogenesis capacity by inhibiting the expression of SIK1 and activating the PI3K/AKT pathway in HUVECs. This evidence concerns the gene AKT1 and hepatocellular carcinoma.